Français Néerlandais Japonais Chinois Allemand Espagnol Portugais

Lille’s Macopharma uses cell therapy to fight diabetes

07 Apr 2015 | Health Nutrition, A region on the move

Lille-based Macopharma, a major specialist player in pharmaceuticals, has developed an automated culturing system to optimize preservation of pancreatic islets—cells that play a key role in treating diabetes.

Macopharma innovation - Health- Lille Region

Prisma—a pioneer in diabetes therapy

Macopharma’s revolutionary Prisma (Pancreatic Islet System Automate unit) breaks new ground in biotherapy.  The product of four years of R&D, this new machine automatically preserves pancreatic islets, the insulin-secreting cells that are used to treat patients with type 1 diabetes.

Patented technology, bold commercial roll-out

Prisma uses three patented systems: a disposable medical device, a cell chamber that preserves the islets, and a specially optimized cell culture medium. “We’ve already deployed Prisma at three major cell therapy centers,” says Bruno Delorme, head of Biotherapy R&D at Macopharma. “These are Lille’s University Hospital Center (CHRU), our co-developer, plus units in Switzerland and in Sweden.

 

 

Source: Les Echos, Nicole Buyse

 

 

Back to news

News

BASF invests €1M on its Gravelines site

BASF Agri-Production is a subsidiary of the German group BASF, which produces most of the crop protection products marketed by BASF France’s Agro division. The Gravelines plant is expanding its production...

EcoPhos reinvests €35 million back into Hauts-de-France

With the first EcoPhos factory in Dunkirk now up and running, the Belgian phosphate company is already planning to open a second one!

All news